| A | B |
|---|
| Heart failure characterized by inability of the heart to pump blood | Systolic failure |
| Heart failure characterized by an impaired ability of the ventricles to fill during diastole | Diastolic failure |
| The hallmark of systolic dysfunction is a decrease in the left ventricular _____ _____ | Ejection fraction |
| Enlargement of the heart chambers | Dilation |
| An increase in the muscle mass and cardiac wall thickness in response to overwork and strain | Hypertrophy |
| The most common form of initial heart failure | Left sided failure |
| Blood backs up into the left atrium and pulmonary veins in this type of heart failure | Left sided failure |
| Backward blood flow to the right atrium and venous circulation | Right sided failure |
| Peripheral edema and weight gain are signs of this | Right sided failure |
| Dependent part edema, ascites, and anasarca are signs of this | Right sided failure |
| JVD is a sign of this | Right sided failure |
| Hepatomegaly and splenomegaly are signs of this | Right sided failure |
| A condition in which the lung alveoli become filled with serosanguinous fluid | Pulmonary edema |
| A displaced PMI is a sign of this | Left sided failure |
| Crackles may be a sign of this | Left sided failure |
| Dyspnea and orthopnea are symptoms of this | Left sided failure |
| Pulmonary edema is a symptom of this | Left sided failure |
| Wheezing, coughing, and frothy, blood tinged sputum may accompany this | Pulmonary edema (Left sided failure) |
| A complication of CHF, results from increasing pressue in the pleural capillaries | Pleural effusion |
| A complication of CHF, caused by alterations in the normal electrical pathway | Arrhythmias (Atrial fib and VT/VF are common) |
| Used to treat CHF, reduces preload, may be given quickly by IV bolus | Loop diuretics (Lasix and Bumex) |
| A goal of CHF treatment: to ______ intravascualar volume | Decrease |
| A goal of CHF treatment: to _____ venous return (preload) | Decrease |
| A goal of CHF treatment: to _____ afterload | Decrease |
| First line drug for CHF- causes vasodilation, Na and H2O excretion, Side effects include hypotension and chrronic cough | ACE Inhibitors |
| Drugs that improve cardiac contractility to increase cardiac output | Inotropic drugs |
| Useful for CHF with atrial fib to increase the force of contraction and lower the heart rate | Digoxin |
| Most common type of cardiomyopathy | Dilated cardiomyopathy |
| Characterized by cardiomegaly with ventricular dilation, impairment of systolic function, atrial enlargement, and stasis of blood in the LV | Dilated cardiomyopathy |
| Most people with dilated cardiomyopathy eventually develop symptoms of this | CHF |
| Interventions for dilated cardiomyopathy focus on controlling what? | CHF |
| Charcterized by asymmetric myocardial hypertrophy without ventricular dilation | Hypertrophic cardiomyopathy |
| Type of cardiomyopathy often seen in young healthy people, including athletes | Hypertrophic cardiomyopathy |
| Another name for hypertrophic cardiomyopathy | Idiopathic hypertrophic subaortic stenosis (IHSS) |
| The least common cardiomyopathy; the ventricles can't stretch to fill | Restrictive cardiomyopathy |
